91˿Ƶ

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

Published: 14 March 2025

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation...

Latest Alzheimer’s drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy...

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson’s, glioblastoma and dementia

Open Science Office Hours - – Open Hardware

Friday, February 7, 2025 11:30to12:30

Atelier "Matériel Ouvert"...

Hughlings Jackson Lecture: New Insights into Navigation

Tuesday, March 28, 2023 16:00to17:00

Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the...

Pages

The Neuro logo91˿Ƶ logo

The Neuro (Montreal Neurological Institute-Hospital)is a bilingual academic healthcare institution. We are a91˿Ƶ research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the 91˿Ƶ Health Centre.We areproud to be a Killam Institution, supported by the Killam Trusts.

Back to top